Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis.
Essential oil from Pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating Th1/Treg cell balance.
Using Functional Electrical Stimulation Mediated by Iterative Learning Control and Robotics to Improve Arm Movement for People With Multiple Sclerosis.
Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Human glial chimeric mice reveal astrocytic dependence of JC virus infection.
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.
How type I interferons shape myeloid cell function in CNS autoimmunity.
Quantitative Susceptibility Mapping in Multiple Sclerosis.
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
Molecular pathogenesis of neuromyelitis optica.
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
Pages
« first
‹ previous
…
298
299
300
301
302
303
304
305
306
…
next ›
last »